Learn More Information About the Palmer Study
Palmer, et al. in their retrospective review, confirmed the prevailing hypothesis that increased levels of synthetic estrogen in the form of DES given to pregnant women correlated with the future development of breast cancer. These authors showed upon longer-term follow-up that DES is indeed associated with the development of breast cancer in women over the age of 40. The reason is that the breast cancer causing effects of DES simply required a longer period of time to be noticeable in the body. The authors obtained information from four large groups of women, 4,817 in all, whose mothers were exposed to DES and compared them to a control group of 2,073 women whose mothers were not given DES.
All other potentially confounding variables were controlled in the analysis of their data. Overall, there was a 40% increased risk of breast cancer in DES daughters, but the risk was over 90% higher in women over the age of 40. The risk was especially high, essentially double for DES daughters who were exposed after the 9th week in utero. In view of this finding, daughters of DES exposed women will require lifelong screening for breast cancer and should probably avoid hormone-based contraception.
Nationwide DES and Breast Cancer Attorneys
In evaluating and planning for the presentation of these cases, we must look at all these factors:
- Dosage
- Timing
- Age at onset
- Obesity
- Ashkenazi Jewish
- Radiation
- BRCA
- Family Risk Factors
- HRTs
- Radial Scars
- Histopathology
- Law of the State of Exposure
- Law of the State of Diagnosis
- Extent of Disease
- Death
- Grade
- Size
- Lymphatic Invasion
- Lymph Nodes
- ER/PR Results
- Location
- Treatment Regimens
- T-Score
- Stage (Tumor, Nodes, Metastasis)
- Treatment
- Proof of Exposure
- Proof of Product Identification
All other potentially confounding variables were controlled in the analysis of their data. Overall, there was a 40% increased risk of breast cancer in DES daughters, but the risk was over 90% higher in women over the age of 40. The risk was especially high, essentially double for DES daughters who were exposed after the 9th week in utero. In view of this finding, daughters of DES exposed women will require lifelong screening for breast cancer and should probably avoid hormone-based contraception.
Though significant, we feel that a continuation of the Palmer study is important. The women's health experts at Aaron M. Levine & Associates believe that this study allows for further research into the relationship between utero DES exposure and breast cancer in DES daughters. We believe so strongly in this, that we are financing an investigation to pick up where the Palmer Study left off, in hopes of gaining a better understanding of the relationship between DES and breast cancer.
Contact Our Firm to Schedule a No-risk Case Evaluation
For more information regarding the Palmer Study and link between DES and breast cancer, contact the Washington lawyers at the law firm of Aaron M. Levine & Associates. Call us toll free to schedule a free case evaluation at 888-564-9305.
